| 000 | 01677 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513214934.0 | ||
| 264 | 0 | _c20000829 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0014-5793 | ||
| 024 | 7 |
_a10.1016/s0014-5793(00)01825-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoeslinger, T | |
| 245 | 0 | 0 |
_aInhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line. _h[electronic resource] |
| 260 |
_bFEBS letters _cJul 2000 |
||
| 300 |
_a95-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xmetabolism |
| 650 | 0 | 4 |
_aArteriosclerosis _xmetabolism |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
| 650 | 0 | 4 |
_aHypochlorous Acid _xmetabolism |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aLipoprotein(a) _xmetabolism |
| 650 | 0 | 4 |
_aMacrophages _xcytology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 700 | 1 | _aFriedl, R | |
| 700 | 1 | _aVolf, I | |
| 700 | 1 | _aBrunner, M | |
| 700 | 1 | _aKoller, E | |
| 700 | 1 | _aSpieckermann, P G | |
| 773 | 0 |
_tFEBS letters _gvol. 478 _gno. 1-2 _gp. 95-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-5793(00)01825-1 _zAvailable from publisher's website |
| 999 |
_c10872108 _d10872108 |
||